fulvestrant has been researched along with Heart Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cong, H; Li, D; Liu, J; Lu, Y; Tian, W; Wei, A; Yang, L; Zhuo, Y | 1 |
| Feng, W; Kan, Y; Li, B; Yang, H; Zeng, M; Zhang, B; Zhang, L; Zheng, X | 1 |
2 other study(ies) available for fulvestrant and Heart Diseases
| Article | Year |
|---|---|
Syringaresinol attenuates sepsis-induced cardiac dysfunction by inhibiting inflammation and pyroptosis in mice.
Topics: Animals; Cardiotonic Agents; Cinnamates; Disease Models, Animal; Fulvestrant; Furans; Heart; Heart Diseases; Humans; Indoles; Inflammation; Lignans; Male; Mice; Molecular Docking Simulation; Myocardium; Pyroptosis; Receptors, Estrogen; Sepsis; Sirtuin 1 | 2021 |
Chinese yam extract and adenosine attenuated LPS-induced cardiac dysfunction by inhibiting RAS and apoptosis via the ER-mediated activation of SHC/Ras/Raf1 pathway.
Topics: Adenosine; Animals; Apoptosis; Cytokines; Dioscorea; Drugs, Chinese Herbal; Female; Fulvestrant; Heart; Heart Diseases; Lipopolysaccharides; Mitogen-Activated Protein Kinases; Myocardium; Myocytes, Cardiac; Proto-Oncogene Proteins c-raf; ras Proteins; Rats, Wistar; Receptors, Estrogen; Renin-Angiotensin System; Shc Signaling Adaptor Proteins | 2019 |